Prestige Consumer Healthcare Closes LaCorium Deal, Prices $400M Notes
Prestige Consumer Healthcare finalized its LaCorium Health acquisition, launched a $400M senior notes offering, and set an August earnings date.
Prestige Consumer Healthcare Inc. (NYSE: PBH) announced Monday from its Tarrytown, N.Y., headquarters that it has officially closed its acquisition of LaCorium Health, simultaneously pricing a private offering of $400 million in senior notes to help fund its expanded operations.
The dual moves signal an aggressive growth push by Prestige, which is deploying debt capital markets alongside the strategic deal to bolster its consumer healthcare portfolio. The $400 million senior notes offering was priced as a private placement, meaning it is not registered under public securities laws and targets institutional investors.
Read more Ripple Earns Full Crypto License Upgrade in Luxembourg →
Adding LaCorium Health to its brand roster deepens Prestige's footprint in the over-the-counter consumer healthcare space, a segment the company has historically grown through targeted acquisitions. The financial terms of the LaCorium deal were not disclosed in Monday's announcement.
Investors looking for a fuller picture of how these transactions affect the company's balance sheet and revenue trajectory will not have to wait long. Prestige confirmed it will release first quarter fiscal 2027 earnings results on August 6, 2026, giving analysts their first opportunity to assess the combined entity's performance under new ownership.
Continue reading at GlobalNewswire.
